Plain-English translation of NCT07187830 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at how semaglutide, a medication used to treat type 2 diabetes, affects where your body stores fat and the health of your liver. Researchers will use special imaging scans (MRI) to take detailed pictures and compare people who are taking this medication to those who are not, to see if there are any differences in how their bodies respond.
People with both type 2 diabetes and chronic kidney disease often struggle with weight and liver health. Doctors want to understand whether this medication helps improve these issues in patients with kidney disease, since most research has focused on people without kidney problems.
You likely qualify if…
You likely don't qualify if…
If you join, you will come to the hospital for one imaging appointment where you'll have an MRI scan of your belly to measure fat around your heart, liver, and kidneys. The researchers will also ask you questions about your medical history, the medications you take, and collect basic information like your age, weight, and height. The entire visit will take place at the university hospital's imaging center.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Canada